Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease-recent updates and open questions
- PMID: 37886211
- PMCID: PMC10598308
- DOI: 10.21037/hbsn-23-376
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease-recent updates and open questions
Keywords: Guidelines; fibrosis; individualized medicine; non-alcoholic steatohepatitis (NASH).
Conflict of interest statement
Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-376/coif). VML is CEO and shareholder of HepaPredict AB.
Comment on
-
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17. Hepatology. 2023. PMID: 36727674 Free PMC article. No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources